November 6, 2006 (Press Release) --
According to a recent news release by Doctor N.D.Dave, ninety percent (90%) of men reported improved erections when taking Cialis. Get to know Cialis, the first tablet for erectile dysfunction (ED) that gives you up to 36 hours to choose the moment that's right for you and your partner. Cialis is the latest innovation by pharmaceutical and drug manufacturer Eli Lilly in an attempt to capture the lucrative international anti-impotence market.
“We view Cialis as best in class and estimate Cialis sales could potentially exceed $1.5 billion in 2010," the analyst said.
Cialis has fared somewhat better, with sales of $456 million in the first half of last year. This summer, analysts started viewing the drug more favorably as prescriptions for it rose more than 20%. Now, Cialis is expected to hit $1 billion in annual sales, next year, according to Lilly.
FDA has approved Cialis for the treatment of men who experience difficulty having and maintaining an erection (impotence). Although there are other drugs on the market for this indication, this drug is different in that it may work up to 36 hours after dosing.
The impotence drug, will now carry a warning about the risk of possible blindness, after the U.S. Food and Drug Administration (FDA) has approved new labelling, Viagra and two other popular impotence drugs may cause sudden blindness in one eye in rare cases, the US Food and Drug Administration has warned. men about possible vision loss by these drugs,.Viagra( By pfizer) and other drugs, for erectile dysfunction like Cialis, the impotence drug marketed by Eli Lilly & Co. and ICOS Corp.
"It makes sense," Barbara Ryan, an analyst with Deutsche Bank Securities in Greenwich, Conn., said about the deal. "This allows them to maximize the economics of their collaboration while eliminating all the redundancies of the joint venture." For more information on cialis treatment options, please visit http://www.sexualhealthnet.info/cialis.html.
“We view Cialis as best in class and estimate Cialis sales could potentially exceed $1.5 billion in 2010," the analyst said.
Cialis has fared somewhat better, with sales of $456 million in the first half of last year. This summer, analysts started viewing the drug more favorably as prescriptions for it rose more than 20%. Now, Cialis is expected to hit $1 billion in annual sales, next year, according to Lilly.
FDA has approved Cialis for the treatment of men who experience difficulty having and maintaining an erection (impotence). Although there are other drugs on the market for this indication, this drug is different in that it may work up to 36 hours after dosing.
The impotence drug, will now carry a warning about the risk of possible blindness, after the U.S. Food and Drug Administration (FDA) has approved new labelling, Viagra and two other popular impotence drugs may cause sudden blindness in one eye in rare cases, the US Food and Drug Administration has warned. men about possible vision loss by these drugs,.Viagra( By pfizer) and other drugs, for erectile dysfunction like Cialis, the impotence drug marketed by Eli Lilly & Co. and ICOS Corp.
"It makes sense," Barbara Ryan, an analyst with Deutsche Bank Securities in Greenwich, Conn., said about the deal. "This allows them to maximize the economics of their collaboration while eliminating all the redundancies of the joint venture." For more information on cialis treatment options, please visit http://www.sexualhealthnet.info/cialis.html.

Cialis is the latest innovation by pharmaceutical and drug manufacturer Eli Lilly in an attempt to capture the lucrative international anti-impotence market.
Email
Print
SPAM





